Login to Your Account

Zai zooms ahead with $30M series A from international investors

By Shannon Ellis
Staff Writer

Tuesday, September 2, 2014
SHANGHAI – Zai Lab Inc., of Shanghai, has received $30 million in financing from a group of international venture capital investors, led by the well-respected Qiming Venture Partners LLC, headquartered in Hong Kong. The series A funding will support Zai's pursuit of its "virtual" business model, and the in-licensing and developing of innovative drugs for global markets as well as China.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription